{"": [92, 472, 0, 473, 940, 0, 941, 1939, 0, 1940, 2141, 0], "Introduction": [2142, 5845, 0], "SARS-CoV-2-infected K18 mice developed severe COVID-19": [5855, 9556, 0], "Lung disease is the primary determinant of COVID-19 severity in K18 mice": [9557, 11607, 0], "SARS-CoV-2 infection causes EC activation and dysfunction": [11608, 13764, 0], "SARS-CoV-2 infects ECs": [13765, 15489, 0], "SARS-CoV-2-mediated EC activation is also seen in the lungs of SARS-CoV-2-infected NHPs and a human patient": [15490, 16958, 0], "RNA seq, scRNA seq, lung tissue array, and serum cytokine analyses": [16959, 21622, 0], "Results": [5846, 21622, 1], "Discussion": [21623, 33701, 0], "Mice and ethics statement": [33711, 33990, 0], "SARS-CoV-2 strain and infection": [33991, 35390, 0], "RNA isolation": [35391, 35631, 0], "Subgenomic N viral copy number detection": [35632, 36108, 0], "Tissue mRNA array": [36109, 36369, 0], "Bulk RNA sequencing": [36370, 40068, 0], "Immunohistochemistry assay": [40069, 40790, 0], "RNA-scope": [40791, 41700, 0], "Immunostaining": [41701, 42232, 0], "Scanning EM": [42233, 42547, 0], "Transmission EM": [42548, 42763, 0], "Statistics": [42764, 43097, 0], "Methods": [33702, 43097, 1], "Supplementary Material": [43098, 43195, 0]}